PneumoWave Achieves 510(k) Clearance For Data Collection Product
[Glasgow, Scotland – Tuesday, 6th May, 2025] We’re pleased to share that PneumoWave has received Class II FDA 510(k) clearance for our Data Collection Mobile
May 6, 2025
[Glasgow, Scotland – Tuesday, 6th May, 2025] We’re pleased to share that PneumoWave has received Class II FDA 510(k) clearance for our Data Collection Mobile
There is no excerpt because this is a protected post.
[Glasgow, Scotland – Thursday 31st October, 2024] https://www.gov.uk/government/news/virtual-reality-and-wearable-technology-pilot-to-cut-drug-deaths Government awards £12 million to research projects across the UK that are researching innovative technology to support
[Glasgow, Scotland – Monday 23rd September, 2024] https://www.researchprotocols.org/2024/1/e57367 A joint paper was published in JMIR Research Protocols, vol 13 (2024), detailing the OD-SEEN (Overdose Sensor
PneumoWave, an innovator in the fight against the opioidepidemic, is proud to announce that it has achieved ISO 13485:2016 certification and has registered aversion of its technology as a Class 1 UKCA device.
UK-based startup PneumoWave devises a chest-worn smart biosensor. The biosensor captures respiratory data and the startup’s platform analyses it using machine learning algorithms
PneumoWave, an innovator in the fight against the opioid epidemic with operations in Scotland and the U.S., proudly announces the appointment of Nicola Broughton as its new Non-Executive Director.